Preclinical: NPY has already been demonstrated preclinically and clinically as a potent neuromodulator in PTSD, MDD, and stress disorders, and NPY-expressing striatal interneurons have been correlated with striatal pathology in HD patients and animal models of HD. The gene discussed is NPY; the disease is post-traumatic stress disorder.